Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Coagulation time; other methods

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 85348 refers to a laboratory test that measures coagulation time using methods other than those specifically defined by other codes. Coagulation time is a critical parameter in assessing the blood's ability to clot, which is essential for normal hemostasis. This test quantifies the duration, in minutes, that it takes for a blood sample to form a clot after the addition of specific reagents or under certain conditions. The measurement of coagulation time is particularly important in evaluating platelet function, which plays a vital role in the clotting process. Code 85348 is applicable when the coagulation time evaluation does not fall under the more defined categories such as Lee-White or activated coagulation time tests, which have their own specific codes. This allows for flexibility in coding when the exact method of coagulation assessment is not specified, ensuring that healthcare providers can accurately report the laboratory services rendered.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The coagulation time test, represented by CPT® Code 85348, is indicated for various clinical scenarios where assessment of the blood's clotting ability is necessary. This test may be performed in the following situations:

  • Assessment of Bleeding Disorders This test is crucial for evaluating patients who present with unexplained bleeding or bruising, as it helps identify potential deficiencies in platelet function or other coagulation factors.
  • Monitoring Anticoagulant Therapy Patients undergoing treatment with anticoagulants may require regular monitoring of their coagulation status to ensure therapeutic effectiveness and to prevent complications such as excessive bleeding.
  • Preoperative Evaluation Prior to surgical procedures, assessing coagulation time can help determine a patient's risk of bleeding, guiding clinical decisions regarding the need for further testing or interventions.
  • Evaluation of Liver Function Since the liver produces many coagulation factors, this test can be part of a broader assessment of liver function, particularly in patients with liver disease.

2. Procedure

The procedure for measuring coagulation time using CPT® Code 85348 involves several key steps that ensure accurate results. The following outlines the procedural steps:

  • Sample Collection A blood sample is collected from the patient, typically via venipuncture. The sample must be handled carefully to avoid contamination and ensure that the results reflect the patient's true coagulation status.
  • Preparation of the Sample The collected blood sample is processed in the laboratory. This may involve the addition of specific reagents that initiate the coagulation process, depending on the method used for the test.
  • Measurement of Coagulation Time The laboratory technician monitors the time it takes for the blood sample to form a clot. This is done using specialized equipment that can accurately measure the time interval from the initiation of coagulation until a stable clot is formed.
  • Result Interpretation Once the coagulation time is measured, the results are analyzed and interpreted by a qualified healthcare professional. The findings are then documented and reported to the ordering physician for further clinical decision-making.

3. Post-Procedure

After the coagulation time test is completed, there are several considerations for post-procedure care. Patients may be advised to monitor for any signs of bleeding or bruising at the venipuncture site, although complications are rare. The results of the test will typically be communicated to the healthcare provider who ordered the test, and any necessary follow-up actions will be determined based on the findings. If the coagulation time is abnormal, further testing or adjustments to anticoagulant therapy may be warranted. It is essential for healthcare providers to discuss the results with the patient and outline any additional steps that may be required for their care.

Short Descr COAGULATION TIME OTR METHOD
Medium Descr COAGULATION TIME OTHER METHODS
Long Descr Coagulation time; other methods
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
Date
Action
Notes
2013-01-01 Changed Short Descriptor changed.
Pre-1990 Added Code added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"